Education
About Us
Working with TipRanks
Follow Us
Aker BioMarine ASA (DE:1PG)
STUTTGART:1PG
1PG Stock Chart & Stats
€7.46
€0.08(1.49%)
At close: 4:00 PM EST
€7.46
€0.08(1.49%)
Day’s Range― - ―
52-Week Range€3.72 - €7.94
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€639.42M
Enterprise Value€6.92B
Total Cash (Recent Filing)€15.00M
Total Debt (Recent Filing)€147.50M
Price to Earnings (P/E)3.9
Beta0.82
Next Earnings
Oct 31, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding87,703,400
10 Day Avg. Volume0
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aker BioMarine ASA News
1PG FAQ
What was Aker BioMarine ASA’s price range in the past 12 months?
Aker BioMarine ASA lowest stock price was €3.72 and its highest was €7.94 in the past 12 months.
What is Aker BioMarine ASA’s market cap?
Aker BioMarine ASA’s market cap is €639.42M.
When is Aker BioMarine ASA’s upcoming earnings report date?
Aker BioMarine ASA’s upcoming earnings report date is Oct 31, 2025 which is tomorrow.
How were Aker BioMarine ASA’s earnings last quarter?
Aker BioMarine ASA released its earnings results on Jul 11, 2025. The company reported -€0.069 earnings per share for the quarter, missing the consensus estimate of >-€0.001 by -€0.068.
Is Aker BioMarine ASA overvalued?
According to Wall Street analysts Aker BioMarine ASA’s price is currently Overvalued.
Does Aker BioMarine ASA pay dividends?
Aker BioMarine ASA does not currently pay dividends.
What is Aker BioMarine ASA’s EPS estimate?
Aker BioMarine ASA’s EPS estimate is 0.
How many shares outstanding does Aker BioMarine ASA have?
Aker BioMarine ASA has 87,703,400 shares outstanding.
What happened to Aker BioMarine ASA’s price movement after its last earnings report?
Aker BioMarine ASA reported an EPS of -€0.069 in its last earnings report, missing expectations of >-€0.001. Following the earnings report the stock price went up 1.767%.
Which hedge fund is a major shareholder of Aker BioMarine ASA?
Currently, no hedge funds are holding shares in DE:1PG
Company Description
Aker BioMarine ASA
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Technical Analysis
Options Prices
Currently, No data available
---